| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 25 | 2024 | 474 | 4.680 |
Why?
|
| Muscular Dystrophy, Duchenne | 10 | 2024 | 39 | 2.750 |
Why?
|
| Annexin A6 | 6 | 2022 | 10 | 2.010 |
Why?
|
| Muscular Dystrophies | 7 | 2024 | 54 | 1.900 |
Why?
|
| Muscle Proteins | 8 | 2021 | 129 | 1.900 |
Why?
|
| Cell Membrane | 9 | 2021 | 664 | 1.810 |
Why?
|
| Membrane Proteins | 11 | 2021 | 1264 | 1.760 |
Why?
|
| Muscular Dystrophy, Animal | 8 | 2019 | 21 | 1.660 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 53 | 1.600 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 464 | 1.580 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 6 | 2024 | 15 | 1.310 |
Why?
|
| Dysferlin | 6 | 2024 | 14 | 1.230 |
Why?
|
| Calcium | 4 | 2022 | 1176 | 1.080 |
Why?
|
| Mice, Inbred mdx | 5 | 2024 | 15 | 1.050 |
Why?
|
| Muscle Development | 6 | 2019 | 39 | 1.020 |
Why?
|
| Dried Blood Spot Testing | 3 | 2021 | 9 | 1.000 |
Why?
|
| Vesicular Transport Proteins | 3 | 2015 | 70 | 0.930 |
Why?
|
| Muscles | 3 | 2024 | 184 | 0.890 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2495 | 0.890 |
Why?
|
| Vaccines, Synthetic | 2 | 2021 | 56 | 0.860 |
Why?
|
| Mice | 28 | 2025 | 12269 | 0.810 |
Why?
|
| Animals | 37 | 2025 | 28155 | 0.750 |
Why?
|
| Myoblasts | 7 | 2024 | 33 | 0.740 |
Why?
|
| Sarcolemma | 10 | 2019 | 30 | 0.740 |
Why?
|
| Sarcoglycans | 7 | 2024 | 13 | 0.730 |
Why?
|
| Membrane Fusion | 3 | 2021 | 37 | 0.720 |
Why?
|
| Myocytes, Cardiac | 8 | 2024 | 313 | 0.710 |
Why?
|
| Neuromuscular Diseases | 1 | 2021 | 27 | 0.700 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 7 | 0.700 |
Why?
|
| Biomarkers | 3 | 2024 | 1910 | 0.690 |
Why?
|
| Family Characteristics | 2 | 2022 | 52 | 0.690 |
Why?
|
| Serologic Tests | 2 | 2021 | 41 | 0.690 |
Why?
|
| Annexins | 2 | 2022 | 6 | 0.680 |
Why?
|
| Pandemics | 5 | 2023 | 873 | 0.640 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2024 | 135 | 0.630 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 116 | 0.610 |
Why?
|
| Exons | 3 | 2019 | 450 | 0.600 |
Why?
|
| Gene Editing | 1 | 2019 | 51 | 0.600 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2022 | 59 | 0.590 |
Why?
|
| Antibodies, Viral | 6 | 2022 | 322 | 0.550 |
Why?
|
| Health Personnel | 1 | 2020 | 234 | 0.550 |
Why?
|
| Muscle Cells | 1 | 2017 | 16 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.510 |
Why?
|
| Prednisone | 4 | 2024 | 242 | 0.510 |
Why?
|
| Protein Transport | 8 | 2016 | 438 | 0.500 |
Why?
|
| Health | 1 | 2015 | 27 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.450 |
Why?
|
| Disease | 1 | 2015 | 92 | 0.440 |
Why?
|
| Neutralization Tests | 4 | 2022 | 72 | 0.440 |
Why?
|
| Glucocorticoids | 5 | 2024 | 362 | 0.440 |
Why?
|
| Muscular Diseases | 3 | 2023 | 67 | 0.420 |
Why?
|
| Dynamin II | 1 | 2014 | 15 | 0.420 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 11 | 0.420 |
Why?
|
| Proteostasis | 2 | 2024 | 12 | 0.420 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 8 | 0.410 |
Why?
|
| Male | 20 | 2025 | 44557 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3476 | 0.400 |
Why?
|
| Glycerol | 1 | 2013 | 34 | 0.400 |
Why?
|
| Actins | 1 | 2016 | 467 | 0.390 |
Why?
|
| Fibrosis | 4 | 2023 | 230 | 0.370 |
Why?
|
| Mice, Knockout | 6 | 2024 | 2121 | 0.370 |
Why?
|
| Gene Expression | 3 | 2019 | 1301 | 0.360 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 162 | 0.360 |
Why?
|
| Antibody Formation | 2 | 2021 | 169 | 0.330 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 56 | 0.330 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2026 | 0.330 |
Why?
|
| Mice, 129 Strain | 3 | 2021 | 56 | 0.330 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 50 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 3435 | 0.320 |
Why?
|
| DNA | 1 | 2015 | 1265 | 0.310 |
Why?
|
| Latent TGF-beta Binding Proteins | 2 | 2021 | 4 | 0.310 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 45 | 0.310 |
Why?
|
| Wound Healing | 4 | 2016 | 373 | 0.310 |
Why?
|
| Female | 16 | 2025 | 48702 | 0.300 |
Why?
|
| Humans | 29 | 2024 | 93515 | 0.280 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 256 | 0.280 |
Why?
|
| Carrier Proteins | 3 | 2021 | 663 | 0.260 |
Why?
|
| Young Adult | 5 | 2024 | 6930 | 0.260 |
Why?
|
| Vaccination | 3 | 2023 | 304 | 0.230 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2850 | 0.230 |
Why?
|
| Myosin Type V | 1 | 2025 | 13 | 0.220 |
Why?
|
| Regeneration | 3 | 2017 | 159 | 0.220 |
Why?
|
| Ataxia | 1 | 2025 | 46 | 0.220 |
Why?
|
| Myosin Heavy Chains | 1 | 2025 | 86 | 0.220 |
Why?
|
| Immunoblotting | 2 | 2016 | 273 | 0.210 |
Why?
|
| Middle Aged | 7 | 2024 | 27573 | 0.210 |
Why?
|
| Adult | 7 | 2024 | 27918 | 0.210 |
Why?
|
| Filamins | 1 | 2024 | 19 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 42 | 0.210 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 291 | 0.210 |
Why?
|
| Myocarditis | 1 | 2024 | 61 | 0.200 |
Why?
|
| Mice, Inbred DBA | 6 | 2024 | 145 | 0.200 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 224 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 304 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 298 | 0.190 |
Why?
|
| Tissue Engineering | 1 | 2024 | 202 | 0.190 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 1587 | 0.190 |
Why?
|
| Calcium-Binding Proteins | 2 | 2021 | 119 | 0.180 |
Why?
|
| Monocytes | 1 | 2023 | 215 | 0.180 |
Why?
|
| Immunologic Tests | 1 | 2021 | 6 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 502 | 0.180 |
Why?
|
| Drug Interactions | 1 | 2021 | 239 | 0.170 |
Why?
|
| Heart Diseases | 1 | 2023 | 257 | 0.170 |
Why?
|
| Mitochondria | 1 | 2025 | 612 | 0.170 |
Why?
|
| Extracellular Vesicles | 1 | 2022 | 47 | 0.170 |
Why?
|
| Steroids | 1 | 2021 | 168 | 0.160 |
Why?
|
| Muscle Contraction | 1 | 2021 | 256 | 0.160 |
Why?
|
| Genes, Modifier | 2 | 2017 | 5 | 0.160 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1621 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2024 | 463 | 0.160 |
Why?
|
| Cell Movement | 1 | 2024 | 809 | 0.160 |
Why?
|
| Chicago | 2 | 2021 | 1464 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 367 | 0.150 |
Why?
|
| Lysosomes | 2 | 2010 | 123 | 0.150 |
Why?
|
| Mutation | 4 | 2025 | 4272 | 0.150 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.150 |
Why?
|
| MyoD Protein | 1 | 2019 | 16 | 0.150 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2019 | 1 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 347 | 0.150 |
Why?
|
| Signal Transduction | 1 | 2009 | 3502 | 0.150 |
Why?
|
| Point Mutation | 1 | 2019 | 238 | 0.140 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1917 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 123 | 0.140 |
Why?
|
| Sarcoglycanopathies | 1 | 2018 | 2 | 0.140 |
Why?
|
| Morpholinos | 1 | 2018 | 13 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 1261 | 0.140 |
Why?
|
| Dystrophin | 4 | 2024 | 24 | 0.140 |
Why?
|
| Adolescent | 2 | 2021 | 9606 | 0.140 |
Why?
|
| Phenotype | 1 | 2024 | 2544 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 988 | 0.130 |
Why?
|
| Protein Binding | 4 | 2022 | 1534 | 0.130 |
Why?
|
| Osteopontin | 1 | 2017 | 48 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1922 | 0.130 |
Why?
|
| Genetic Therapy | 2 | 2018 | 366 | 0.130 |
Why?
|
| Phospholipids | 1 | 2017 | 108 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 436 | 0.120 |
Why?
|
| Exosomes | 1 | 2017 | 60 | 0.120 |
Why?
|
| Base Sequence | 1 | 2019 | 2220 | 0.120 |
Why?
|
| Cell Communication | 1 | 2017 | 216 | 0.120 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2024 | 1691 | 0.120 |
Why?
|
| Electroporation | 1 | 2015 | 59 | 0.120 |
Why?
|
| Creatine Kinase | 1 | 2015 | 51 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 65 | 0.120 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 141 | 0.110 |
Why?
|
| Plasmids | 1 | 2015 | 273 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 282 | 0.110 |
Why?
|
| Intracellular Space | 2 | 2014 | 38 | 0.110 |
Why?
|
| Cell Line | 4 | 2024 | 2464 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2015 | 150 | 0.110 |
Why?
|
| Heterozygote | 1 | 2015 | 382 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2015 | 416 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 2465 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2021 | 3054 | 0.100 |
Why?
|
| Caveolin 3 | 1 | 2014 | 4 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 257 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 894 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 392 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 137 | 0.100 |
Why?
|
| HIV Infections | 1 | 2023 | 961 | 0.100 |
Why?
|
| Aged | 2 | 2021 | 20434 | 0.100 |
Why?
|
| Cell Survival | 1 | 2015 | 1004 | 0.100 |
Why?
|
| Endosomes | 2 | 2010 | 86 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2014 | 198 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2017 | 580 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1985 | 0.080 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 6 | 0.080 |
Why?
|
| Cardiotoxins | 1 | 2010 | 3 | 0.080 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 5 | 0.080 |
Why?
|
| Myoblasts, Skeletal | 1 | 2009 | 4 | 0.080 |
Why?
|
| Myofibrils | 1 | 2009 | 20 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2010 | 139 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 282 | 0.070 |
Why?
|
| Models, Biological | 1 | 2015 | 1768 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2484 | 0.070 |
Why?
|
| Endocytosis | 1 | 2008 | 184 | 0.060 |
Why?
|
| RNA Splicing | 2 | 2019 | 157 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 962 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2006 | 26 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2022 | 696 | 0.060 |
Why?
|
| Annexin A2 | 1 | 2024 | 2 | 0.050 |
Why?
|
| Decorin | 1 | 2024 | 6 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2006 | 603 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2024 | 50 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2024 | 145 | 0.050 |
Why?
|
| Bortezomib | 1 | 2024 | 82 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2024 | 139 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2023 | 37 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 630 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 225 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 740 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 52 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 917 | 0.040 |
Why?
|
| Vero Cells | 1 | 2022 | 99 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2024 | 246 | 0.040 |
Why?
|
| Heart | 1 | 2024 | 522 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 22 | 0.040 |
Why?
|
| Proteomics | 1 | 2023 | 264 | 0.040 |
Why?
|
| Immunoassay | 1 | 2021 | 99 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 517 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 729 | 0.040 |
Why?
|
| Anacardic Acids | 1 | 2019 | 1 | 0.040 |
Why?
|
| Pulse Therapy, Drug | 1 | 2019 | 2 | 0.040 |
Why?
|
| MEF2 Transcription Factors | 1 | 2019 | 9 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 337 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2019 | 1415 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2019 | 45 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 212 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 98 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 109 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1531 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 109 | 0.040 |
Why?
|
| Reading Frames | 1 | 2018 | 6 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1524 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 83 | 0.030 |
Why?
|
| Annexin A1 | 1 | 2017 | 5 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 50 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 160 | 0.030 |
Why?
|
| Urine | 1 | 2018 | 94 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 759 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 51 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 297 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 109 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 47 | 0.030 |
Why?
|
| Neurons | 1 | 2025 | 1582 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 306 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 290 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1052 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 342 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 144 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 829 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 47 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 78 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 555 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2715 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 75 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 756 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 209 | 0.030 |
Why?
|
| Membranes | 1 | 2014 | 35 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 23 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1847 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2014 | 38 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 555 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 362 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 220 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 219 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 5410 | 0.020 |
Why?
|
| Myocardium | 1 | 2015 | 570 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 521 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 630 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2014 | 650 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 555 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 19 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 34 | 0.020 |
Why?
|
| Child | 1 | 2019 | 7355 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 209 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 352 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2006 | 36 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 98 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 2005 | 11 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2012 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 2910 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 1353 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 323 | 0.010 |
Why?
|